EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C26H25N3O3S |
| Net Charge | 0 |
| Average Mass | 459.571 |
| Monoisotopic Mass | 459.16166 |
| SMILES | CC[C@H](NC(=O)c1c(NS(C)(=O)=O)c(-c2ccccc2)nc2ccccc12)c1ccccc1 |
| InChI | InChI=1S/C26H25N3O3S/c1-3-21(18-12-6-4-7-13-18)28-26(30)23-20-16-10-11-17-22(20)27-24(19-14-8-5-9-15-19)25(23)29-33(2,31)32/h4-17,21,29H,3H2,1-2H3,(H,28,30)/t21-/m0/s1 |
| InChIKey | QYTBBBAHNIWFOD-NRFANRHFSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | neurokinin-3 receptor antagonist An antagonist at the neurokinin-3 receptor. |
| Application: | antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| pavinetant (CHEBI:140478) has role antipsychotic agent (CHEBI:35476) |
| pavinetant (CHEBI:140478) has role neurokinin-3 receptor antagonist (CHEBI:140482) |
| pavinetant (CHEBI:140478) is a aromatic amide (CHEBI:62733) |
| pavinetant (CHEBI:140478) is a quinolines (CHEBI:26513) |
| pavinetant (CHEBI:140478) is a secondary carboxamide (CHEBI:140325) |
| pavinetant (CHEBI:140478) is a sulfonamide (CHEBI:35358) |
| IUPAC Name |
|---|
| 3-[(methanesulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide |
| INNs | Source |
|---|---|
| pavinétant | WHO MedNet |
| pavinetantum | WHO MedNet |
| pavinetant | WHO MedNet |
| pavinetant | WHO MedNet |
| Synonyms | Source |
|---|---|
| AZD2624 | ChemIDplus |
| AZD4901 | ChemIDplus |
| AZD-2624 | ChemIDplus |
| MLE4901 | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| DB11692 | DrugBank |
| Pavinetant | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:12927851 | Reaxys |
| CAS:941690-55-7 | ChemIDplus |
| Citations |
|---|